Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending October 14, 2023 (Week 41)
Reporting Area Chlamydia trachomatis infection §
Current weekPrevious 52 weeks Max †Cum YTD 2023 †Cum YTD 2022 †
U.S. Residents, excluding U.S. Territories 14,804 32,999 1,164,287 1,315,783
New England 185 1,650 31,132 41,774
Connecticut - 430 1,155 9,807
Maine 39 74 2,340 2,508
Massachusetts - 700 20,417 22,589
New Hampshire 31 82 2,230 2,283
Rhode Island 87 694 3,942 3,569
Vermont 28 37 1,048 1,018
Middle Atlantic 2,817 4,177 155,024 152,792
New Jersey 488 789 27,489 26,413
New York (excluding New York City) 847 1,032 33,043 31,627
New York City 746 1,495 52,296 51,102
Pennsylvania 736 1,232 42,196 43,650
East North Central 1,809 4,622 153,866 181,164
Illinois 84 1,811 40,003 56,454
Indiana 457 860 24,819 26,769
Michigan 291 975 26,019 33,903
Ohio 634 1,213 43,403 43,483
Wisconsin 343 562 19,622 20,555
West North Central 879 2,082 72,153 80,976
Iowa 152 333 10,651 11,754
Kansas 174 280 6,833 11,262
Minnesota 97 497 16,860 17,640
Missouri 423 746 25,270 25,613
Nebraska - 246 6,910 7,650
North Dakota - 91 1,786 2,920
South Dakota 33 125 3,843 4,137
South Atlantic 3,165 7,719 259,396 292,789
Delaware 227 210 4,470 4,039
District of Columbia - 199 5,456 6,490
Florida 1,748 2,786 89,064 83,778
Georgia - 1,550 51,705 58,240
Maryland U NC U 24,093
North Carolina 10 1,445 45,978 51,529
South Carolina 523 774 26,311 28,538
Virginia 626 976 32,983 32,467
West Virginia 31 107 3,429 3,615
East South Central 1,007 2,456 74,902 88,351
Alabama 551 972 26,967 24,669
Kentucky 345 552 13,131 14,422
Mississippi 111 487 14,554 18,742
Tennessee - 1,094 20,250 30,518
West South Central 449 4,800 152,163 186,150
Arkansas 176 435 13,467 14,341
Louisiana 258 844 28,338 29,055
Oklahoma 15 473 12,421 16,440
Texas - 3,106 97,937 126,314
Mountain 1,343 2,485 85,073 93,790
Arizona 426 870 31,578 32,904
Colorado 445 782 19,868 20,676
Idaho 2 148 4,410 4,646
Montana 41 93 2,512 3,320
Nevada 192 343 9,626 12,948
New Mexico 11 241 7,039 9,000
Utah 206 254 8,782 8,865
Wyoming 20 50 1,258 1,431
Pacific 3,150 5,049 180,578 197,997
Alaska 51 121 3,302 4,280
California 2,384 4,112 149,642 153,721
Hawaii - 132 - 4,391
Oregon 298 382 11,981 12,482
Washington 417 590 15,653 23,123
U.S. Territories - 124 1,138 3,677
American Samoa - 0 - -
Commonwealth of Northern Mariana Islands - 0 - -
Guam - 0 - -
Puerto Rico - 124 1,138 3,677
U.S. Virgin Islands - 0 - -
Non-U.S. Residents 1 7 42 114
Total 14,805 33,085 1,165,467 1,319,574
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2022 and 2023 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2022, only confirmed cases are published to align with the approved CSTE position statement 21-ID-06, whereas in previous years, all case classification statuses were published. This change may cause a decrease in published case counts when compared to previous years.